バイオシミラーモノクローナル抗体の世界市場（～2026年）

• 英文タイトル：Global Biosimilar Monoclonal Antibody Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY11096
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はバイオシミラーモノクローナル抗体のグローバル市場について調査・分析したレポートです。種類別（合成化学品、生物医薬品、その他）市場規模、用途別（慢性・自己免疫疾患、腫瘍、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別バイオシミラーモノクローナル抗体の競争状況、市場シェア
・世界のバイオシミラーモノクローナル抗体市場：種類別市場規模 2015年-2020年（合成化学品、生物医薬品、その他）
・世界のバイオシミラーモノクローナル抗体市場：種類別市場規模予測 2021年-2026年（合成化学品、生物医薬品、その他）
・世界のバイオシミラーモノクローナル抗体市場：用途別市場規模 2015年-2020年（慢性・自己免疫疾患、腫瘍、その他）
・世界のバイオシミラーモノクローナル抗体市場：用途別市場規模予測 2021年-2026年（慢性・自己免疫疾患、腫瘍、その他）
・北米のバイオシミラーモノクローナル抗体市場分析：米国、カナダ
・ヨーロッパのバイオシミラーモノクローナル抗体市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのバイオシミラーモノクローナル抗体市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のバイオシミラーモノクローナル抗体市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのバイオシミラーモノクローナル抗体市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Biocon、Accord Healthcare、AET Biotech、Amgen、Celltrion、Reddy's Laboratories、Hospira、3SBio、Allergan、Alvartis
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Biosimilar monoclonal antibodies (mAbs) are complex, large proteins of the biosimilar family used by the immune system to identify and neutralize foreign bodies, such as bacteria, viruses, and others. These antibodies are normally administered in the treatment of diseases such as rheumatoid arthritis, Hodgkins lymphoma, chronic lymphocytic leukemia, and others.

Market Analysis and Insights: Global Biosimilar Monoclonal Antibody Market
The global Biosimilar Monoclonal Antibody market size is projected to reach US$ 5942.7 million by 2026, from US$ 4574.3 million in 2020, at a CAGR of 27.7%% during 2021-2026.

Global Biosimilar Monoclonal Antibody Scope and Market Size
Biosimilar Monoclonal Antibody market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar Monoclonal Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Biocon
Accord Healthcare
AET Biotech
Amgen
Celltrion
Reddy’s Laboratories
Hospira
3SBio
Allergan
Alvartis

Market segment by Type, the product can be split into
Synthetic Chemicals
Biopharmaceuticals
Others
Market segment by Application, split into
Chronic & Autoimmune Diseases
Oncology
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biosimilar Monoclonal Antibody Revenue
1.4 Market by Type
1.4.1 Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Synthetic Chemicals
1.4.3 Biopharmaceuticals
1.4.4 Others
1.5 Market by Application
1.5.1 Global Biosimilar Monoclonal Antibody Market Share by Application: 2020 VS 2026
1.5.2 Chronic & Autoimmune Diseases
1.5.3 Oncology
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Biosimilar Monoclonal Antibody Market Perspective (2015-2026)
2.2 Global Biosimilar Monoclonal Antibody Growth Trends by Regions
2.2.1 Biosimilar Monoclonal Antibody Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biosimilar Monoclonal Antibody Historic Market Share by Regions (2015-2020)
2.2.3 Biosimilar Monoclonal Antibody Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biosimilar Monoclonal Antibody Market Growth Strategy
2.3.6 Primary Interviews with Key Biosimilar Monoclonal Antibody Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Monoclonal Antibody Players by Market Size
3.1.1 Global Top Biosimilar Monoclonal Antibody Players by Revenue (2015-2020)
3.1.2 Global Biosimilar Monoclonal Antibody Revenue Market Share by Players (2015-2020)
3.1.3 Global Biosimilar Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biosimilar Monoclonal Antibody Market Concentration Ratio
3.2.1 Global Biosimilar Monoclonal Antibody Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biosimilar Monoclonal Antibody Revenue in 2019
3.3 Biosimilar Monoclonal Antibody Key Players Head office and Area Served
3.4 Key Players Biosimilar Monoclonal Antibody Product Solution and Service
3.5 Date of Enter into Biosimilar Monoclonal Antibody Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Biosimilar Monoclonal Antibody Historic Market Size by Type (2015-2020)
4.2 Global Biosimilar Monoclonal Antibody Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)
5.2 Global Biosimilar Monoclonal Antibody Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Biosimilar Monoclonal Antibody Market Size (2015-2020)
6.2 Biosimilar Monoclonal Antibody Key Players in North America (2019-2020)
6.3 North America Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
6.4 North America Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)

7 Europe
7.1 Europe Biosimilar Monoclonal Antibody Market Size (2015-2020)
7.2 Biosimilar Monoclonal Antibody Key Players in Europe (2019-2020)
7.3 Europe Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
7.4 Europe Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)

8 China
8.1 China Biosimilar Monoclonal Antibody Market Size (2015-2020)
8.2 Biosimilar Monoclonal Antibody Key Players in China (2019-2020)
8.3 China Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
8.4 China Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)

9 Japan
9.1 Japan Biosimilar Monoclonal Antibody Market Size (2015-2020)
9.2 Biosimilar Monoclonal Antibody Key Players in Japan (2019-2020)
9.3 Japan Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
9.4 Japan Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Biosimilar Monoclonal Antibody Market Size (2015-2020)
10.2 Biosimilar Monoclonal Antibody Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
10.4 Southeast Asia Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)

11 India
11.1 India Biosimilar Monoclonal Antibody Market Size (2015-2020)
11.2 Biosimilar Monoclonal Antibody Key Players in India (2019-2020)
11.3 India Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
11.4 India Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Biosimilar Monoclonal Antibody Market Size (2015-2020)
12.2 Biosimilar Monoclonal Antibody Key Players in Central & South America (2019-2020)
12.3 Central & South America Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
12.4 Central & South America Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Biocon
13.1.1 Biocon Company Details
13.1.2 Biocon Business Overview
13.1.3 Biocon Biosimilar Monoclonal Antibody Introduction
13.1.4 Biocon Revenue in Biosimilar Monoclonal Antibody Business (2015-2020))
13.1.5 Biocon Recent Development
13.2 Accord Healthcare
13.2.1 Accord Healthcare Company Details
13.2.2 Accord Healthcare Business Overview
13.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Introduction
13.2.4 Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
13.2.5 Accord Healthcare Recent Development
13.3 AET Biotech
13.3.1 AET Biotech Company Details
13.3.2 AET Biotech Business Overview
13.3.3 AET Biotech Biosimilar Monoclonal Antibody Introduction
13.3.4 AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
13.3.5 AET Biotech Recent Development
13.4 Amgen
13.4.1 Amgen Company Details
13.4.2 Amgen Business Overview
13.4.3 Amgen Biosimilar Monoclonal Antibody Introduction
13.4.4 Amgen Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
13.4.5 Amgen Recent Development
13.5 Celltrion
13.5.1 Celltrion Company Details
13.5.2 Celltrion Business Overview
13.5.3 Celltrion Biosimilar Monoclonal Antibody Introduction
13.5.4 Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
13.5.5 Celltrion Recent Development
13.6 Reddy’s Laboratories
13.6.1 Reddy’s Laboratories Company Details
13.6.2 Reddy’s Laboratories Business Overview
13.6.3 Reddy’s Laboratories Biosimilar Monoclonal Antibody Introduction
13.6.4 Reddy’s Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
13.6.5 Reddy’s Laboratories Recent Development
13.7 Hospira
13.7.1 Hospira Company Details
13.7.2 Hospira Business Overview
13.7.3 Hospira Biosimilar Monoclonal Antibody Introduction
13.7.4 Hospira Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
13.7.5 Hospira Recent Development
13.8 3SBio
13.8.1 3SBio Company Details
13.8.2 3SBio Business Overview
13.8.3 3SBio Biosimilar Monoclonal Antibody Introduction
13.8.4 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
13.8.5 3SBio Recent Development
13.9 Allergan
13.9.1 Allergan Company Details
13.9.2 Allergan Business Overview
13.9.3 Allergan Biosimilar Monoclonal Antibody Introduction
13.9.4 Allergan Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
13.9.5 Allergan Recent Development
13.10 Alvartis
13.10.1 Alvartis Company Details
13.10.2 Alvartis Business Overview
13.10.3 Alvartis Biosimilar Monoclonal Antibody Introduction
13.10.4 Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
13.10.5 Alvartis Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Biosimilar Monoclonal Antibody Key Market Segments
Table 2. Key Players Covered: Ranking by Biosimilar Monoclonal Antibody Revenue
Table 3. Ranking of Global Top Biosimilar Monoclonal Antibody Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Synthetic Chemicals
Table 6. Key Players of Biopharmaceuticals
Table 7. Key Players of Others
Table 8. Global Biosimilar Monoclonal Antibody Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Biosimilar Monoclonal Antibody Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Biosimilar Monoclonal Antibody Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Biosimilar Monoclonal Antibody Market Share by Regions (2015-2020)
Table 12. Global Biosimilar Monoclonal Antibody Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Biosimilar Monoclonal Antibody Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Biosimilar Monoclonal Antibody Market Growth Strategy
Table 18. Main Points Interviewed from Key Biosimilar Monoclonal Antibody Players
Table 19. Global Biosimilar Monoclonal Antibody Revenue by Players (2015-2020) (Million US$)
Table 20. Global Biosimilar Monoclonal Antibody Market Share by Players (2015-2020)
Table 21. Global Top Biosimilar Monoclonal Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Monoclonal Antibody as of 2019)
Table 22. Global Biosimilar Monoclonal Antibody by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Biosimilar Monoclonal Antibody Product Solution and Service
Table 25. Date of Enter into Biosimilar Monoclonal Antibody Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Biosimilar Monoclonal Antibody Market Size by Type (2015-2020) (Million US$)
Table 28. Global Biosimilar Monoclonal Antibody Market Size Share by Type (2015-2020)
Table 29. Global Biosimilar Monoclonal Antibody Revenue Market Share by Type (2021-2026)
Table 30. Global Biosimilar Monoclonal Antibody Market Size Share by Application (2015-2020)
Table 31. Global Biosimilar Monoclonal Antibody Market Size by Application (2015-2020) (Million US$)
Table 32. Global Biosimilar Monoclonal Antibody Market Size Share by Application (2021-2026)
Table 33. North America Key Players Biosimilar Monoclonal Antibody Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Biosimilar Monoclonal Antibody Market Share (2019-2020)
Table 35. North America Biosimilar Monoclonal Antibody Market Size by Type (2015-2020) (Million US$)
Table 36. North America Biosimilar Monoclonal Antibody Market Share by Type (2015-2020)
Table 37. North America Biosimilar Monoclonal Antibody Market Size by Application (2015-2020) (Million US$)
Table 38. North America Biosimilar Monoclonal Antibody Market Share by Application (2015-2020)
Table 39. Europe Key Players Biosimilar Monoclonal Antibody Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Biosimilar Monoclonal Antibody Market Share (2019-2020)
Table 41. Europe Biosimilar Monoclonal Antibody Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Biosimilar Monoclonal Antibody Market Share by Type (2015-2020)
Table 43. Europe Biosimilar Monoclonal Antibody Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Biosimilar Monoclonal Antibody Market Share by Application (2015-2020)
Table 45. China Key Players Biosimilar Monoclonal Antibody Revenue (2019-2020) (Million US$)
Table 46. China Key Players Biosimilar Monoclonal Antibody Market Share (2019-2020)
Table 47. China Biosimilar Monoclonal Antibody Market Size by Type (2015-2020) (Million US$)
Table 48. China Biosimilar Monoclonal Antibody Market Share by Type (2015-2020)
Table 49. China Biosimilar Monoclonal Antibody Market Size by Application (2015-2020) (Million US$)
Table 50. China Biosimilar Monoclonal Antibody Market Share by Application (2015-2020)
Table 51. Japan Key Players Biosimilar Monoclonal Antibody Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Biosimilar Monoclonal Antibody Market Share (2019-2020)
Table 53. Japan Biosimilar Monoclonal Antibody Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Biosimilar Monoclonal Antibody Market Share by Type (2015-2020)
Table 55. Japan Biosimilar Monoclonal Antibody Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Biosimilar Monoclonal Antibody Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Biosimilar Monoclonal Antibody Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Biosimilar Monoclonal Antibody Market Share (2019-2020)
Table 59. Southeast Asia Biosimilar Monoclonal Antibody Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Biosimilar Monoclonal Antibody Market Share by Type (2015-2020)
Table 61. Southeast Asia Biosimilar Monoclonal Antibody Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Biosimilar Monoclonal Antibody Market Share by Application (2015-2020)
Table 63. India Key Players Biosimilar Monoclonal Antibody Revenue (2019-2020) (Million US$)
Table 64. India Key Players Biosimilar Monoclonal Antibody Market Share (2019-2020)
Table 65. India Biosimilar Monoclonal Antibody Market Size by Type (2015-2020) (Million US$)
Table 66. India Biosimilar Monoclonal Antibody Market Share by Type (2015-2020)
Table 67. India Biosimilar Monoclonal Antibody Market Size by Application (2015-2020) (Million US$)
Table 68. India Biosimilar Monoclonal Antibody Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Biosimilar Monoclonal Antibody Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Biosimilar Monoclonal Antibody Market Share (2019-2020)
Table 71. Central & South America Biosimilar Monoclonal Antibody Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Biosimilar Monoclonal Antibody Market Share by Type (2015-2020)
Table 73. Central & South America Biosimilar Monoclonal Antibody Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Biosimilar Monoclonal Antibody Market Share by Application (2015-2020)
Table 75. Biocon Company Details
Table 76. Biocon Business Overview
Table 77. Biocon Product
Table 78. Biocon Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (Million US$)
Table 79. Biocon Recent Development
Table 80. Accord Healthcare Company Details
Table 81. Accord Healthcare Business Overview
Table 82. Accord Healthcare Product
Table 83. Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (Million US$)
Table 84. Accord Healthcare Recent Development
Table 85. AET Biotech Company Details
Table 86. AET Biotech Business Overview
Table 87. AET Biotech Product
Table 88. AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (Million US$)
Table 89. AET Biotech Recent Development
Table 90. Amgen Company Details
Table 91. Amgen Business Overview
Table 92. Amgen Product
Table 93. Amgen Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (Million US$)
Table 94. Amgen Recent Development
Table 95. Celltrion Company Details
Table 96. Celltrion Business Overview
Table 97. Celltrion Product
Table 98. Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (Million US$)
Table 99. Celltrion Recent Development
Table 100. Reddy's Laboratories Company Details
Table 101. Reddy's Laboratories Business Overview
Table 102. Reddy's Laboratories Product
Table 103. Reddy's Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (Million US$)
Table 104. Reddy's Laboratories Recent Development
Table 105. Hospira Company Details
Table 106. Hospira Business Overview
Table 107. Hospira Product
Table 108. Hospira Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (Million US$)
Table 109. Hospira Recent Development
Table 110. 3SBio Business Overview
Table 111. 3SBio Product
Table 112. 3SBio Company Details
Table 113. 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (Million US$)
Table 114. 3SBio Recent Development
Table 115. Allergan Company Details
Table 116. Allergan Business Overview
Table 117. Allergan Product
Table 118. Allergan Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (Million US$)
Table 119. Allergan Recent Development
Table 120. Alvartis Company Details
Table 121. Alvartis Business Overview
Table 122. Alvartis Product
Table 123. Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (Million US$)
Table 124. Alvartis Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilar Monoclonal Antibody Market Share by Type: 2020 VS 2026
Figure 2. Synthetic Chemicals Features
Figure 3. Biopharmaceuticals Features
Figure 4. Others Features
Figure 5. Global Biosimilar Monoclonal Antibody Market Share by Application: 2020 VS 2026
Figure 6. Chronic & Autoimmune Diseases Case Studies
Figure 7. Oncology Case Studies
Figure 8. Others Case Studies
Figure 9. Biosimilar Monoclonal Antibody Report Years Considered
Figure 10. Global Biosimilar Monoclonal Antibody Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Biosimilar Monoclonal Antibody Market Share by Regions: 2020 VS 2026
Figure 12. Global Biosimilar Monoclonal Antibody Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Biosimilar Monoclonal Antibody Market Share by Players in 2019
Figure 15. Global Top Biosimilar Monoclonal Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Monoclonal Antibody as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Biosimilar Monoclonal Antibody Revenue in 2019
Figure 17. North America Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

以下、関連資料のご紹介

モノクローナル抗体療法の世界市場（～2026年）

Global Monoclonal Antibody Therapy Market Size, Status and Forecast 2020-2026
MRC2-11QY03847 2020年11月20日 92Pages
当調査資料はモノクローナル抗体療法のグローバル市場について調査・分析したレポートです。種類別（組換え、キメラ、ヒト化、ヒト）市場規模、用途別（診断検査、分析および化学、癌治療、自己免疫疾患、造血系疾患）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、ア...

モノクローナル抗体ベース製品の世界市場（～2026年）

Global Monoclonal Antibody Based Products Market Size, Status and Forecast 2020-2026
MRC2-11QY03844 2020年11月20日 96Pages
当調査資料はモノクローナル抗体ベース製品のグローバル市場について調査・分析したレポートです。種類別（がん、自己免疫、炎症性、感染性、微生物性、ウイルス性疾患）市場規模、用途別（病院、研究、学術機関、診療所、診断研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...

モノクローナル抗体カスタムサービスの世界市場（～2026年）

Global Monoclonal Antibody Custom Service Market Size, Status and Forecast 2020-2026
MRC2-11QY03845 2020年11月20日 90Pages
当調査資料はモノクローナル抗体カスタムサービスのグローバル市場について調査・分析したレポートです。種類別（ラットカスタムモノクローナル抗体、ウサギカスタムモノクローナル抗体）市場規模、用途別（診断用、治療用、タンパク質精製）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

モノクローナル抗体サービスの世界市場（～2026年）

Global Monoclonal Antibody Service Market Size, Status and Forecast 2020-2026
MRC2-11QY03846 2020年11月20日 131Pages
当調査資料はモノクローナル抗体サービスのグローバル市場について調査・分析したレポートです。種類別（試薬、医薬品、その他）市場規模、用途別（診断研究所、研究所、学術研究所、製薬・バイオテクノロジー企業）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

次世代抗体療法の世界市場（～2026年）

Global Next Generation Antibody Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY03969 2020年11月20日 95Pages
当調査資料は次世代抗体療法のグローバル市場について調査・分析したレポートです。種類別（抗体薬物複合体（ADC）、二重特異性抗体（BsAbs）、Fc改変抗体、抗体フラグメントおよび抗体様タンパク質（AFおよびALP）、バイオシミラー抗体（Ab）製品）市場規模、用途別（病院、診療所、その他）市場規模、地...

モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年）

Global Monoclonal antibodies (mAbs) Biosimilars Market Size, Status and Forecast 2020-2026
MRC2-11QY03843 2020年11月20日 90Pages
当調査資料はモノクローナル抗体(mAb)バイオシミラーのグローバル市場について調査・分析したレポートです。種類別（エリスロポエチン（EPO）、ヒト成長ホルモン（HGH）、顆粒球コロニー刺激因子（G-CSF）、モノクローナル抗体（mAb）、インスリン、インターフェロン（IFN）、その他）市場規模、用途...

バイオシミラー試験・開発サービスの世界市場（～2026年）

Global Biosimilar Testing and Development Services Market Size, Status and Forecast 2020-2026
MRC2-11QY11097 2020年11月25日 96Pages
当調査資料はバイオシミラー試験・開発サービスのグローバル市場について調査・分析したレポートです。種類別（エフェクター結合、ELISA、キネティック結合アッセイ、ADCC・CDC細胞ベースアッセイ）市場規模、用途別（PKアッセイ、階層型免疫原性試験、NAbアッセイ）市場規模、地域別（北米、米国、カナダ...

抗体ライブラリー技術の世界市場（～2026年）

Global Antibody Library Technologies Market Size, Status and Forecast 2020-2026
MRC2-11QY10863 2020年11月25日 94Pages
当調査資料は抗体ライブラリー技術のグローバル市場について調査・分析したレポートです。種類別（ファージディスプレイ、リボソームディスプレイ、酵母ディスプレイ、哺乳類細胞ディスプレイ）市場規模、用途別（バイオ製薬会社、学術・研究機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラ...

併用抗体療法の世界市場（～2026年）

Global Combination Antibody Therapy Market Size, Status and Forecast 2020-2026
MRC2-11QY11438 2020年11月25日 96Pages
当調査資料は併用抗体療法のグローバル市場について調査・分析したレポートです。種類別（化学療法/抗体、抗体/抗体、コンジュゲート抗体、二重特異性抗体）市場規模、用途別（病院、がん研究所、クリニック、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、...

抗体薬物複合体（ADC）の世界市場（～2026年）

Global Antibody Drug Conjugates (ADCs) Market Size, Status and Forecast 2020-2026
MRC2-11QY10862 2020年11月25日 94Pages
当調査資料は抗体薬物複合体（ADC）のグローバル市場について調査・分析したレポートです。種類別（シアトルジェネティクス技術、イミュノジェン技術、イミュノメディクス技術）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

モノクローナル抗体療法の世界市場（～2026年） Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…
モノクローナル抗体ベース製品の世界市場（～2026年） Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins. This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodie…
モノクローナル抗体カスタムサービスの世界市場（～2026年） Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…
モノクローナル抗体サービスの世界市場（～2026年） Market Analysis and Insights: Global Monoclonal Antibody Service Market The global Monoclonal Antibody Service market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Monoclonal Antibody Service Scope and Market Size Monoclona…
モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…